Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04064190
Title Vactosertib With Durvalumab in Urothelial Carcinoma Failing Checkpoint Inhibition
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedPacto, Inc.

urethra transitional cell carcinoma

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma


Durvalumab + TEW 7197

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.